University of California San Francisco
Give to UCSFJoe DeRisi, PhD, a master detective of infectious diseases, stumbled on a clue to cracking the decades-long search for the place – or creature – where the Ebola virus hides between deadly outbreaks.
Global Health Sciences is celebrating the 10th anniversary of the Global Health Group, and it has a long list of accomplishments to claim from that time.
UCSF Health Informatics team has used electronic health records to track down a source of a common hospital-acquired infection.
A genome sequencing test developed at UCSF that can rapidly pinpoint the cause of a bacterial, viral, fungal or parasitic infection is now available to help physicians nationwide diagnose cases.
Anna Molofsky and Shaeri Mukherjee were among the 22 early-career researchers in the 2017 class announced June 15 by The Pew Charitable Trusts.
How T cells feel out intruders rapidly and reliably enough to nip infections and other threats in the bud has remained a mystery to researchers.
UCSF researcher Grant Dorsey received federal funding for the Program for Resistance, Immunology, Surveillance and Modeling of Malaria in Uganda.
UCSF researchers have helped to identify the three evolutionary steps the polio virus used to evolve from harmless vaccine into a regional menace. With the new knowledge, they have developed a new polio vaccine that should be unable to escape and cause outbreaks.
Researcher Annesa Flentje is looking at ways stress among sexual minorities – those whose sexual orientation, identity or practices differ from the majority – can affect physical and mental health, starting at the genetic level, with a particular focus of late on the effect of stress on HIV-positive men.
Two things brought Roly Gosling to his current work to eliminate malaria: a series of British children’s books he read as a boy and a conviction that he should put his vision and beliefs into practice.
The mammalian placenta is a sort of armored car protecting a developing fetus. All manner of infectious agents attempt to break in, but few of them can. Scientists are working to understand why some infections do break through and how to stop them.
A novel gene therapy treatment may save infants from SCID, a devastating immune disorder commonly known as "bubble boy disease".
A type of herpes virus that infects about half of the U.S. population has been associated with risk factors for type 2 diabetes and heart disease in normal-weight women aged 20 to 49.
The problem of antibiotic resistance and how research may help keep drugs effective was the topic of this year’s Byers Award Lecture in Basic Science, given by Danica Galonić Fujimori, PhD, on Jan. 31.
Fifteen UCSF faculty members have been named to the first cohort of Chan Zuckerberg Biohub Investigators.
There are an estimated 150,000 HIV-infected children in Uganda, and studies indicate less than a third of children under the age of 15 know they are infected.
People with bipolar disorder, schizophrenia and major depression with psychosis may be up to 15 more likely than the general population to be HIV positive, but are only marginally more likely to be tested for the virus.
A newly identified bacterial protein that is shown to jump-start infection may be the culprit in a foodborne disease that strikes pregnant women in disproportionately high numbers, leading to miscarriage and pre-term birth.
Stories about sensory processing disorder, videos about “zombie” cancer cells, and news about the effects of caffeine and alcohol on the heart were among the topics that most engaged our readers in 2016.
The Malaria Elimination Group is meeting this week in Chennai, India, to discuss strategies to shrink the global malaria map and take stock of India’s efforts to eliminate the disease.
UCSF researchers identified fetal brain tissue cells that are targeted by the Zika virus and determined that azithromycin can prevent the virus from infecting these cells.
The Bill & Melinda Gates Foundation has awarded UCSF’s Global Health Group’s Malaria Elimination Initiative (MEI) a four-year grant of $29 million to accelerate malaria elimination.
UCSF researchers are learning more about what guides the formation of crystals that malaria parasites leave behind so they can work toward new treatments.